Acquired factor V inhibitor: a nation‐wide study of 38 patients

Summary Acquired factor V inhibitor (AFVI) is an extremely rare disorder that may cause severe bleeding. To identify factors associated with bleeding risk in AFVI patients, a national, multicentre, retrospective study was made including all AFVI patients followed in 21 centres in France between 1988...

Full description

Saved in:
Bibliographic Details
Published in:British journal of haematology 2021-03, Vol.192 (5), p.892-899
Main Authors: Goulenok, Tiphaine, Vasco, Claire, Faille, Dorothée, Ajzenberg, Nadine, De Raucourt, Emmanuelle, Dupont, Annabelle, Frere, Corinne, James, Chloé, Rabut, Elodie, Rugeri, Lucia, Schleinitz, Nicolas, Sacré, Karim, Papo, Thomas, Barbay, Virginie, Becar, Pierre, Laure Bigel, Marie, Boehlen, Françoise, Darnige, Luc, de Raucourt, Emmanuelle, Dubois, Philippe, Dumas de la Roque, Gerard, Flaujac, Claire, Harlé, Jean‐Robert, Jourde, Noémie, Khelef, Sabrina, Lacombe, Yves, Langlois, Michel, Lebreton, Aurélien, Leflem, Léna, Mamou, Patrick, Massignon, Denis, Meley, Roland, Michel, Marc, Mutuon, Pierre, Pineau Vincent, Fabienne, Reigner, Antoine, Repesse, Yohann, Rossignol, Benoit, Ryman, Anne, Tieulie, Nathalie, Vasse, Marc, Voisin, Sophie
Format: Article
Language:English
Subjects:
acquired factor V inhibitor
Bleeding
Coagulation factors
Diagnosis
Factor V
factor V inhibitor clearance
Hematology
Life Sciences
Prothrombin
prothrombin time
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Acquired factor V inhibitor (AFVI) is an extremely rare disorder that may cause severe bleeding. To identify factors associated with bleeding risk in AFVI patients, a national, multicentre, retrospective study was made including all AFVI patients followed in 21 centres in France between 1988 and 2015. All patients had an isolated factor V (FV) deficiency
ISSN:0007-1048
1365-2141
DOI:10.1111/bjh.17308